- Home
- CZFS vs BDTX Comparison
CZFS vs BDTX Comparison
Compare CZFS & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | BDTX |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.6M | 220.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CZFS | BDTX |
|---|---|---|
| Price | $59.05 | $2.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.60 |
| AVG Volume (30 Days) | 9.5K | ★ 1.7M |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.40% | N/A |
| EPS Growth | ★ 24.64 | N/A |
| EPS | ★ 7.10 | 0.38 |
| Revenue | ★ $107,399,000.00 | $70,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.45 | N/A |
| P/E Ratio | $8.29 | ★ $6.72 |
| Revenue Growth | ★ 9.73 | N/A |
| 52 Week Low | $49.96 | $1.20 |
| 52 Week High | $66.96 | $4.94 |
Technical Indicators
Market Signals| Indicator | CZFS | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 31.68 |
| Support Level | $60.78 | $2.48 |
| Resistance Level | $63.18 | $2.72 |
| Average True Range (ATR) | 1.96 | 0.23 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 47.78 | 31.30 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.